Results
|
7181.
|
|
|
7182.
|
|
|
7183.
|
|
|
7184.
|
|
|
7185.
|
|
|
7186.
|
|
|
7187.
|
|
|
7188.
|
Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group. [electronic resource] by
- Faulkner, Eric
- Annemans, Lieven
- Garrison, Lou
- Helfand, Mark
- Holtorf, Anke-Peggy
- Hornberger, John
- Hughes, Dyfrig
- Li, Tracy
- Malone, Daniel
- Payne, Katherine
- Siebert, Uwe
- Towse, Adrian
- Veenstra, David
- Watkins, John
Producer: 20130220
In:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 15
Availability: No items available.
|
|
7189.
|
|
|
7190.
|
|
|
7191.
|
|
|
7192.
|
|
|
7193.
|
|
|
7194.
|
Feasibility of implementing a comprehensive warfarin pharmacogenetics service. [electronic resource] by
- Nutescu, Edith A
- Drozda, Katarzyna
- Bress, Adam P
- Galanter, William L
- Stevenson, James
- Stamos, Thomas D
- Desai, Ankit A
- Duarte, Julio D
- Gordeuk, Victor
- Peace, David
- Kadkol, Shrihari S
- Dodge, Carol
- Saraf, Santosh
- Garofalo, John
- Krishnan, Jerry A
- Garcia, Joe G N
- Cavallari, Larisa H
Producer: 20150212
In:
Pharmacotherapy vol. 33
Availability: No items available.
|
|
7195.
|
|
|
7196.
|
|
|
7197.
|
|
|
7198.
|
|
|
7199.
|
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin. [electronic resource] by
- Dooley, Kelly E
- Luetkemeyer, Anne F
- Park, Jeong-Gun
- Allen, Reena
- Cramer, Yoninah
- Murray, Stephen
- Sutherland, Deborah
- Aweeka, Francesca
- Koletar, Susan L
- Marzan, Florence
- Bao, Jing
- Savic, Rada
- Haas, David W
Producer: 20150921
In:
Antimicrobial agents and chemotherapy vol. 58
Availability: No items available.
|
|
7200.
|
|